Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ANIK

Anika Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · ANIK

All alert types
20.95 USD -0.84 -3.85%
As of Oct 30, 2026 Extended hours 20.95 0.00%
Bid
20.92 × 2
Ask
20.94 × 2
20.81 Day range 21.80
9.13 52-week range 22.03
YTD
+118.00%
1 year
+114.21%
Open
21.80
Prev close
21.79
Mkt cap
280.37M
Vol
66.70K
Avg vol
109.82K
EPS
-0.23
P/E
0.00
Div yield
0.00%
More statistics
Low
20.81
High
21.80
Forward P/E
-81.65
Beta
0.86
Short ratio
2.43
Inst. own
91.59%
Dividend
0.00
Ex-div date
50-d avg
19.11
200-d avg
24.14
1y target
26.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ANIK has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

5.20 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -12.6×
FY 2016: 22.1×FY 2017: 24.7×FY 2018: 25.9×FY 2019: 26.9×FY 2020: -26.8×FY 2021: 124×FY 2022: -29.0×FY 2023: -4.0×FY 2024: -4.3×FY 2025: -12.6×
FY 2016 5y median -4.3× FY 2025
P/S 1.2×
FY 2016: 7.0×FY 2017: 6.9×FY 2018: 4.6×FY 2019: 6.4×FY 2020: 4.9×FY 2021: 3.5×FY 2022: 3.8×FY 2023: 2.7×FY 2024: 2.0×FY 2025: 1.2×
FY 2016 5y median 2.7× FY 2025
P/B 1.0×
FY 2016: 3.2×FY 2017: 3.0×FY 2018: 1.8×FY 2019: 2.5×FY 2020: 2.4×FY 2021: 1.8×FY 2022: 1.5×FY 2023: 1.6×FY 2024: 1.6×FY 2025: 1.0×
FY 2016 5y median 1.6× FY 2025
P/FCF 31.6×
FY 2016: 73.4×FY 2017: 24.7×FY 2018: 16.0×FY 2019: 21.4×FY 2020: 56.3×FY 2021: 159×FY 2022: -140×FY 2023: -46.0×FY 2024: -104×FY 2025: 31.6×
FY 2016 5y median -46.0× FY 2025
EV/EBITDA -29.8×
FY 2016: 11.3×FY 2017: 13.0×FY 2018: 14.3×FY 2019: 14.8×FY 2020: -568×FY 2021: -106×FY 2022: 20.0×FY 2023: 16.8×FY 2024: 39.7×FY 2025: -29.8×
FY 2016 5y median 16.8× FY 2025
EV/Sales 0.9×
FY 2016: 5.9×FY 2017: 5.8×FY 2018: 3.8×FY 2019: 5.2×FY 2020: 4.4×FY 2021: 3.0×FY 2022: 3.3×FY 2023: 2.4×FY 2024: 1.8×FY 2025: 0.9×
FY 2016 5y median 2.4× FY 2025
FCF Yield 3.2%
FY 2016: 1.4%FY 2017: 4.1%FY 2018: 6.2%FY 2019: 4.7%FY 2020: 1.8%FY 2021: 0.6%FY 2022: -0.7%FY 2023: -2.2%FY 2024: -1.0%FY 2025: 3.2%
FY 2016 5y median -0.7% FY 2025

Profitability

Gross Margin 56.6%
FY 2016: 76.8%FY 2017: 75.9%FY 2018: 70.4%FY 2019: 74.9%FY 2020: 52.9%FY 2021: 56.1%FY 2022: 64.3%FY 2023: 68.3%FY 2024: 63.4%FY 2025: 56.6%
FY 2016 5y median 63.4% FY 2025
Operating Margin -9.8%
FY 2016: 49.0%FY 2017: 40.3%FY 2018: 20.6%FY 2019: 29.9%FY 2020: -21.7%FY 2021: 1.8%FY 2022: 3.2%FY 2023: 0.7%FY 2024: -4.3%FY 2025: -9.8%
FY 2016 5y median 0.7% FY 2025
Net Margin -9.6%
FY 2016: 31.5%FY 2017: 28.1%FY 2018: 17.7%FY 2019: 23.7%FY 2020: -18.4%FY 2021: 2.8%FY 2022: -13.1%FY 2023: -68.4%FY 2024: -47.0%FY 2025: -9.6%
FY 2016 5y median -13.1% FY 2025
ROE -7.6%
FY 2016: 14.6%FY 2017: 12.1%FY 2018: 7.1%FY 2019: 9.4%FY 2020: -8.8%FY 2021: 1.4%FY 2022: -5.2%FY 2023: -38.9%FY 2024: -36.6%FY 2025: -7.6%
FY 2016 5y median -7.6% FY 2025
ROIC -6.5%
FY 2016: 14.0%FY 2017: 11.7%FY 2018: 6.6%FY 2019: 8.2%FY 2020: -7.2%FY 2021: 0.8%FY 2022: 0.6%FY 2023: -0.4%FY 2024: -2.8%FY 2025: -6.5%
FY 2016 5y median -0.4% FY 2025
ROA -5.7%
FY 2016: 13.5%FY 2017: 11.3%FY 2018: 6.7%FY 2019: 8.2%FY 2020: -6.6%FY 2021: 1.2%FY 2022: -4.3%FY 2023: -30.5%FY 2024: -27.8%FY 2025: -5.7%
FY 2016 5y median -5.7% FY 2025

Growth (YoY)

Revenue -5.9%
FY 2016: 11.2%FY 2017: 9.7%FY 2018: -6.9%FY 2019: 8.6%FY 2020: 13.8%FY 2021: 13.3%FY 2022: -23.0%FY 2023: 6.1%FY 2024: -0.7%FY 2025: -5.9%
FY 2016 FY 2025
Operating Income -116.6%
FY 2016: 5.1%FY 2017: -9.6%FY 2018: -52.4%FY 2019: 57.5%FY 2020: -182.7%FY 2021: 109.2%FY 2022: 40.3%FY 2023: -77.0%FY 2024: -704.4%FY 2025: -116.6%
FY 2016 FY 2025
EPS (diluted) 80.2%
FY 2016: 7.0%FY 2017: -1.9%FY 2018: -39.8%FY 2019: 48.8%FY 2020: -189.4%FY 2021: 116.6%FY 2022: -464.3%FY 2023: -452.9%FY 2024: 32.1%FY 2025: 80.2%
FY 2016 FY 2025
Free Cash Flow 287.1%
FY 2016: -67.2%FY 2017: 225.2%FY 2018: -4.9%FY 2019: 12.9%FY 2020: -66.5%FY 2021: -71.5%FY 2022: -194.6%FY 2023: -134.5%FY 2024: 67.7%FY 2025: 287.1%
FY 2016 FY 2025

Financial Health

Current Ratio 4.7×
FY 2016: 19.4×FY 2017: 15.8×FY 2018: 18.0×FY 2019: 14.4×FY 2020: 4.8×FY 2021: 5.7×FY 2022: 6.1×FY 2023: 5.3×FY 2024: 4.9×FY 2025: 4.7×
FY 2016 5y median 5.3× FY 2025
Quick Ratio 3.9×
FY 2016: 17.6×FY 2017: 14.1×FY 2018: 16.1×FY 2019: 13.0×FY 2020: 3.6×FY 2021: 4.4×FY 2022: 4.6×FY 2023: 4.5×FY 2024: 3.9×FY 2025: 3.9×
FY 2016 5y median 4.4× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 8.7×
FY 2016: -1.9×FY 2017: -2.7×FY 2018: -3.2×FY 2019: -3.4×FY 2020: 73.1×FY 2021: 17.6×FY 2022: -2.9×FY 2023: -2.4×FY 2024: -5.5×FY 2025: 8.7×
FY 2016 5y median -2.4× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -35.4×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31